Ontology highlight
ABSTRACT:
SUBMITTER: Davies MJ
PROVIDER: S-EPMC6772132 | biostudies-literature | 2019 Aug
REPOSITORIES: biostudies-literature
Davies Melanie J MJ Russell-Jones David D Barber Thomas M TM Lavalle-González Fernando J FJ Galstyan Gagik R GR Zhu Dalong D Baxter Mike M Dessapt-Baradez Cecile C McCrimmon Rory J RJ
Diabetes, obesity & metabolism 20190618 8
In this post hoc analysis of the randomized controlled LixiLan-O trial in insulin-naive patients with type 2 diabetes mellitus (T2DM) not controlled with metformin, with or without a second oral antihyperglycaemic drug (OAD), the efficacy and safety of the fixed-ratio combination, iGlarLixi (insulin glargine 100 U [iGlar] and lixisenatide [Lixi]), compared to its individual components was assessed in two patient subgroups: group 1) baseline HbA1c ≥9% (n = 134); group 2) inadequate control (HbA1c ...[more]